These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24024331)

  • 1. Fangjihuangqi tang improved lower urinary tract dysfunction in benign prostatic hyperplasia rats model.
    Chen G; Liu H; Cheng F
    J Tradit Chin Med; 2013 Jun; 33(3):349-54. PubMed ID: 24024331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amlodipine alone or combined with terazosin improves lower urinary tract disorder in rat models of benign prostatic hyperplasia or detrusor instability: focus on detrusor overactivity.
    Liu HP; Chen GL; Liu P; Xu XP
    BJU Int; 2009 Dec; 104(11):1752-7. PubMed ID: 19493262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
    Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
    BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inhibitory effect of Berberine from herbal Coptis chinensis Franch on rat detrusor contraction in benign prostatic hyperplasia associated with lower urinary tract symptoms.
    Miao L; Yun X; Yang X; Jia S; Jiao C; Shao R; Hao J; Chang Y; Fan G; Zhang J; Geng Q; Wichai N; Gao X
    J Ethnopharmacol; 2021 Mar; 268():113666. PubMed ID: 33301912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.
    Fwu CW; Eggers PW; Kirkali Z; McVary KT; Burrows PK; Kusek JW
    J Urol; 2014 Jun; 191(6):1828-34. PubMed ID: 24342143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of Tripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats.
    Shen HN; Xu Y; Jiang ZZ; Huang X; Zhang LY; Wang T
    Chin J Nat Med; 2015 Jun; 13(6):421-7. PubMed ID: 26073338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone-induced benign prostatic hyperplasia rat and dog as facile models to assess drugs targeting lower urinary tract symptoms.
    Li J; Tian Y; Guo S; Gu H; Yuan Q; Xie X
    PLoS One; 2018; 13(1):e0191469. PubMed ID: 29351556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bawu decoction () ameliorates benign prostatic hyperplasia in rats.
    Eom JH; Cheon SY; Chung KS; Kim MD; An HJ
    Chin J Integr Med; 2017 Aug; 23(8):611-616. PubMed ID: 27838873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seidlitzia rosmarinus for lower urinary tract symptoms associated with benign prostatic hyperplasia: a pilot randomized controlled clinical trial.
    Heidari M; Hosseinabadi R; Anbari K; Pournia Y; Tarverdian A
    Complement Ther Med; 2014 Aug; 22(4):607-13. PubMed ID: 25146062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of orchiectomy and testosterone replacement on lower urinary tract function in anesthetized rats.
    Cheng CL; de Groat WC
    Am J Physiol Renal Physiol; 2016 Nov; 311(5):F864-F870. PubMed ID: 27534993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.
    Casabé A; Roehrborn CG; Da Pozzo LF; Zepeda S; Henderson RJ; Sorsaburu S; Henneges C; Wong DG; Viktrup L
    J Urol; 2014 Mar; 191(3):727-33. PubMed ID: 24096118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium does not affect lower urinary tract functions in COPD patients with benign prostatic hyperplasia.
    Miyazaki H; Suda T; Otsuka A; Nagata M; Ozono S; Hashimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
    Pulm Pharmacol Ther; 2008 Dec; 21(6):879-83. PubMed ID: 18992357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tadalafil on storage and voiding function in patients with male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A urodynamic-based study.
    Matsukawa Y; Majima T; Matsuo K; Funahashi Y; Kato M; Yamamoto T; Gotoh M
    Int J Urol; 2018 Mar; 25(3):246-250. PubMed ID: 29164680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Suzuki T; Otsuka A; Ozono S
    Int J Urol; 2016 Nov; 23(11):929-933. PubMed ID: 27545297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.
    Glina S; Roehrborn CG; Esen A; Plekhanov A; Sorsaburu S; Henneges C; Büttner H; Viktrup L
    J Sex Med; 2015 Jan; 12(1):129-38. PubMed ID: 25353053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).
    Takahashi R; Miyazato M; Nishii H; Sumino Y; Takayama K; Onzuka M; Oshiro T; Saito S; Fujimoto N; Mimata H; Eto M
    Low Urin Tract Symptoms; 2018 Jan; 10(1):76-83. PubMed ID: 29341501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dutasteride on lower urinary tract symptoms: a prospective analysis based on changes in testosterone/dihydrotestosterone levels and total prostatic volume reduction.
    Shigehara K; Miyagi T; Nakashima T; Izumi K; Kitagawa Y; Mizokami A; Koh E; Shimamura M; Namiki M
    Aging Male; 2016 Jun; 19(2):128-33. PubMed ID: 26890877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
    Porst H; Kim ED; Casabé AR; Mirone V; Secrest RJ; Xu L; Sundin DP; Viktrup L;
    Eur Urol; 2011 Nov; 60(5):1105-13. PubMed ID: 21871706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
    Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
    J Urol; 2013 Jan; 189(1 Suppl):S135-40. PubMed ID: 23234619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-year follow up of silodosin monotherapy for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: What are the factors for continuation or withdrawal?
    Yamanishi T; Kaga K; Fuse M; Shibata C; Kamai T; Uchiyama T
    Int J Urol; 2015 Dec; 22(12):1143-8. PubMed ID: 26310102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.